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The aim of this study is to build a mathematical model of the pancreas and run this model in 
lifelong simulations in order to understand the mechanisms that predict an increased risk of 
pancreatitis. The dilemma is that pancreatitis is a complex process with multiple variables, which 
currently make the onset, severity and outcomes unpredictable in individual patients. Genetic, 
environmental and metabolic factors are likely to be important for disease severity and 
progression, with somewhat stochastic events initiating theprocess when stress leads to injury 
signals. Modeling should begin in the acinar cell, with ability to incorporate duct cells, 
inflammatory cells, other cells and their interactions into large model. In this work we attempted 
to build a foundational model that incorporates the main features and interactors. We built a 
framework that focuses on trypsinogen activation as a major cause of auto-digestion and injury. 
Additional variables such as production ofpancreatic secretory trypsin inhibitor(PSTI) molecules 
as a defense line against active trypsin as well as bicarbonate secretion were included in the 
model. The effects of mutation were modeled as modified rates of trypsinogen 
production/activation, trypsin inactivation, PSTI production, and bicarbonate secretion. Our 
framework contains three compartments that represent domains where trypsin could be activated. 
The domains are acinar cell, lumen of the acinus, and main duct of the pancreas. We used a 
stochastic approach to test the general flow of the simulation.  
The public health and translational significance of this model is thatit would help us to 
understand the physiology of the pancreas more deeply. It wouldalso allow us to consider many 
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factors that lead to pancreatitis and predict their behavior under different conditions (e.g., 
therapy). 
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1.0  INTODUCTION 
The pancreas is a large gland situated in the upper abdominal area that plays an important role in 
our body by performing both endocrine and exocrine functions. The endocrine function is 
achieved by the ability of the pancreas to release hormones like insulin and glucagon into the 
blood stream. These hormones help our body to keep glucose levels within a physiological range. 
The exocrine function is achieved by production and secretion of alkaline juice with digestive 
enzymes that helps to digest food. These enzymes flow from the pancreas to the upper part of the 
small intestines(called the duodenum) via the pancreatic duct. Normally, these digestive enzymes 
become active when they reach the small intestine and in this form they break down the food we 
consume. But when these enzymes become activated within the pancreatic gland they begin to 
digest whatever they meet causinginjury, inflammation, and may produce necrosis and/or 
fibrosis of the pancreas itself. Autodigestion of the pancreas leads to an inflammatory process 
that results in pancreatitis. Clinically we define two types of pancreatitis: acute and chronic 
forms with fast and slow durations respectively. Both formsare serious and in severe cases can 
lead to complications such as bleeding, infection, and permanent tissue damage1-4. 
Under normal physiological conditions, pancreatic juice contains inactive forms of 
several digestive enzymes known as proenzymes or zymogens. Full activation of proenzymes 
occurs only in the small intestine. Enterokinase first converts trypsinogen into active trypsin, and 
the active trypsin goes on to activate more of itself and the rest of the digestive enzymes1-4. There 
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are several defensive mechanisms that prevent early activation of digestive enzymes inside the 
pancreas: in the intracellular stage, proenzymes are stored and transported in vesicles. This 
compartmentalization keeps proenzymes isolated from lysosomal enzymes and preventsthe 
proenzymes from being activated; along with digestive enzymes,the pancreatic acinar cells also 
secrete secretory trypsin inhibitor (PSTI), that has a high affinity for trypsin and blocks its 
proteolytic activity; control of intracellular level of calcium (Ca2+) also plays an important role in 
trypsin stability by reducing trypsin’s degradation rate; and the secretion of sodium-bicarbonate 
rich fluid by duct cells flushes proenzymes from the pancreatic ductal system into the intestine. 
Disruption of these protective mechanisms will increase the risk of early activation of digestive 
enzymes in the pancreas resulting in auto-digestion and pancreatitis1. 
Epidemiologic studies of pancreatitis clearly define a list of associated risk factors. For 
example, the most common risk factor is the presence of gallstones. When the gallstones pass 
through the common bile duct they may become lodged at the junction of the bile and pancreatic 
duct, causing pancreatic juice to be retained in the pancreas. If the proenzymes activate, they will 
cause injury and inflammation in the pancreas that results in acute pancreatitis5-7. Another 
common risk factor is chronic, heavy alcohol consumption that greatly increases the risk of 
developing chronic pancreatitis8-10. Interestingly, alcohol by itself increases the risk only 
marginally, but in population terms it h as a high attributable risk because of the worldwide 
exposure to alcohol. Genetic abnormalities of the pancreas can also lead to increased 
predisposition to develop pancreatitis and explain a subset of patients with hereditary 
pancreatitis11. 
Genetic studies have led to the identification of a number of potential genetic variants 
that contribute to the development of pancreatitis. These haveidentified major risk genes in 
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which mutations can affect early activation of digestive enzymes in the pancreas: the cationic 
trypsinogen gene (PRSS1), the pancreatic secretory trypsin inhibitor gene (PSTI) also known as 
Serine Protease Inhibitor Kazal Type 1 (SPINK1), the cystic fibrosis transmembrane 
conductance regulator gene (CFTR), calcium-sensing receptor gene (CASR), and chymotrypsin 
C gene (CTRC) (Figure 1)8, 12-14. We know that an active form of trypsinogen, trypsin, is a major 
protease that converts the rest of digestive enzymes into their active form. Mutations that 
increase the stability of trypsin will increase the chances of breaking the defense mechanisms 
and over-activating of trypsinogen and other digestive proenzymes. 
PRSS1 mutations that lead to gain of function are risk factors for pancreatitis. PRSS1 
mutations are inherited in autosomal dominant manner and cause hereditary pancreatitis with a 
penetrance of 80%. Among the most common PRSS1 mutations we recognize R122H and N29I 
mutations. The R122H mutation increases trypsin’s resistance to autolysis and permanent 
inactivation. While the N29I mutation alters the structure conformation of trypsinogen, it makes 
trypsinogen tolerant to trypsin inhibitor15-18. 
PSTI molecules are the first defense line against the autodigestion caused by early 
activation of trypsinogen into trypsin. It was believed that PSTI can inhibit up to 20% of trypsin 
activity19. However, normally it is not present in the pancreas except after injury and 
inflammation, which means that PSTI is an acute phase protein that is produced in response to 
inflammation in the pancreas, thus the fraction of trypsin that PSTI can inhibit is dynamically 
regulated. It also makes sense that the mutations in PSTI by themselves donot increase the risk of 
developing pancreatitis, but they accelerate the risk in combination with other mutations that lead 
to recurrent premature trypsin activation12, 19, 20. 
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CFTR is the gene that is responsible for cystic fibrosis when severe mutations are present 
on both alleles. About 2,000 mutations have been described in the human CFTR gene. But only 
those mutations that alter bicarbonate secretion by the pancreatic duct cell are actually essential 
for increased risk of pancreatitis due to the fact that the pancreatic duct cell secretes bicarbonate 
that attracts water into the duct and eases the transportation of digestive enzymes into the 
intestine. In the case of reduced bicarbonate secretion, the flow of pancreatic juice though the 
ducts diminishes, increasing the risk of early trypsin activation. Interestingly a subset of CFTR 
mutations that cause pancreatitis, but that have no effect on l ung, have been described - they 
selectively impede bicarbonate secretion, but not chloride secretion21-23. 
Finally, mutations in both CASR and CTRC genes may increase the risk of chronic 
pancreatitis24, 25. CASR mutations are responsible for elevating serum calcium levels, while 
CTRC mutations are responsible for functional defects in the digestive enzyme chymotrypsin C. 
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Figure 1: Diagram of trypsin control mechanisms in the pancreas 
PRSS1 – protease serine 1; PSTI - pancreatic secretory trypsin inhibitor; SPINK1 – serine protease inhibitor, Kazal 
type 1; CFTR – cystic fibrosis transmembrane conductance regulator; CASR – calcium-sensing receptor gene, 
CTRC – chymotrypsin C gene; AIR – Acute injury response; 
Adapted fromFeldman, M. Friedman, L.S. and Brandt, L.J.Gastrointestinal and Liver Disease (2010). 26 
 
Both environmental and genetic risk factors are responsible for developing of 
pancreatitis. But is pancreatitis important? The statistics for pancreatitis in Table 1 represents the 
US population27. As you can see, the incidence rate of acute pancreatitis is higher compared to 
incidence rate of chronic pancreatitis. In 2004 almost half of all ambulatory care visits ended 
with hospitalizations and roughly 9% of hospitalizations resulted in death. In 2003 t he acute 
pancreatitis admissions cost was approximately $2.2 bi llion, at mean cost of $9,870 pe r 
hospitalization and mean cost of $1,670 per hospitalization day28,based on data on 226,000 acute 
pancreatitis admissions from 37 participating states. Considering the cost of hospitalization 
admissions and the fact that majority of patients are chronic, pancreatitis is a serious public 
health issue. How can we address our work to this matter?  We could build a model to predict 
  6 
therisk of pancreatitis. In order to do that we first need to build a mathematical model of 
pancreas itself and run lifelong simulations of this model. Both acute pancreatitis and chronic 
pancreatitis are syndromes, which means that they are signs and symptoms of underlying 
problem or problems, usually of unknown etiology. Different etiologies, in different amounts and 
various combinations, will have different effects on the pancreas. Additional modifying factors 
further increase variability of the response to injury (e.g., inflammation). The reason to do 
modeling is that we have more than one variable and the overall risk and outcomes are currently 
unpredictable. If we are able to build a model of the pancreas that successfully calculates the risk 
of pancreatitis, itmeans that we finally clearly understand and distinguish different risk factors of 
pancreatitis and can accurately evaluate each of them. It may also help us to predict the resulting 
effects of curtain public health interventions that are directed at reducing pancreatitis. 
 
Table 1.Statistics for pancreatitis. 
Prevalence:   1.1 million people (1998) 
Incidence:  
Acute:    17 cases per 100,000 people (2003) 
Chronic:   8.2 cases per 100,000 people (1981) 
Ambulatory care visits:  881,000 (2004) 
Hospitalizations:    454,000 (2004) 
Mortality:    3,480 deaths (2004) 
Prescriptions:    766,000 (2004) 
Adapted from National Digestive Diseases  Inform ation Clearinghouse (NDDIC)27 
 
In this work, we construct a mathematical model of the pancreas. The model should be as 
simple as possible, but not too simple. For this purpose we focus only on the exocrine function of 
the pancreas (secretion of digestive enzymes). Because of the exclusive role of trypsin in the 
activation of other digestive enzymes, we limit our model to considering trypsin and its 
proenzyme - trypsinogen. Our main task is to observe trypsinogen from the time it is synthesized 
to the time it is flushed to the intestine. This means that we need to model the work of the 
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pancreas from the very beginning, its stimulation, to the very end, secretion of pancreatic juice 
into the intestine. For this purpose we build a general framework of the model in the first place 
and then assign different parts of the model to different compartments of the pancreas and 
synchronize their work. 
  8 
2.0  METHODS 
2.1 DEFINITIONS USED 
2.1.1 Cell definition 
Islet cells and acini are the primary functional units of pancreas1-3. They carry out the endocrine 
and exocrine functions of the pancreas. The acinus has three types of cells, the acinar cell, 
centroacinar cell, and duct cell (Figure 2A). The acinar cell is the dominant cell type in the 
pancreas and is responsible for the synthesis of digestive enzymes in response to food intake. 
Within this protein mixture we are only interested in trypsinogen as a precursor for active trypsin 
and PSTI as a d efense mechanism against active trypsin. We are also interested in calcium 
because it has a direct influence on the rate of trypsin activation. Othermolecules (such as those 
that make the acinar cell work) are less important for our modeling.We are also interested in the 
acinar cell’s “status”, defined as either alive (active) or dead. When alive,the acinar cell can be 
stimulated to produce and secrete trypsinogen andcalcium to the lumen (Figure 2B).The acinar 
cell also secretes PSTI molecules, but only in response to inflammation12, 16, 17. As the PSTI is an 
acute phase inflammatory response molecule and as the assessment of inflammation is being 
made only once a "day", at this stage it is only possible to proceed with modeling PSTI as being 
constitutively produced. This allows us in the model to check whether secreted protective 
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molecules (PSTI) are sufficient to inhibit the damage in the case of early trypsin activation. If 
trypsin is over activated, we switch the status to the “dead” to simulate autolysis. When the 
acinar cell is dead, it does not produce any enzymes and does not contribute to the overall 
secretion. The construction of acinar cell as being alive or dead allow us freely switch between 
these two statuses. We can mimic regeneration processes and recover a pool of lost acinar cells 
by simply turning dead acinar cells intoliving cells once. 
The centroacinar and duct cells are two cell types with similar functions: they produce 
bicarbonate (BC) that attracts water and promotes easy movement (“flushing”) of the digestive 
juice1-4, 29. In our model there is no difference between these two cells in terms of bicarbonate 
production. So we simplified the two cell types into one type (our duct cell) (Figure 2B). This 
duct cell also has two conditions: alive and dead. When alive, it can be stimulated to produce 
bicarbonate and to secrete it into the lumen. 
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Figure 2.Diagram of the acinus. 
A) Diagram of the acinus. Tg – trypsinogen; PSTI - pancreatic secretory trypsin inhibitor ; Ca – calcium; Bc – 
bicarbonate;Copiedfrom D.C. Whitcomb and M.M. Barmada. Cell. and Mol. Life Sciences, 2007; 
B) Scheme used in the model to describe acinus. 
2.1.2 Framework definition 
Acinar cells, by themselves, are not sufficient enough to define a functional unit of the pancreas. 
Hundreds of acinar cells along with centroacinar cells are organized into an acinus, a round 
shaped cluster of cells with an open lumen (cavity) inside1-4 (Figure 2A). This lumen opens to 
the duct, so enzymes secreted to the lumen can flow to the intestine through the duct. Because 
the functional unit of the pancreas, the acinus,needs to secrete both digestive juice and 
bicarbonate (to promote movement of the digestive juice out of the lumen of the acinus), we 
decided to include duct cellsin the acinus and treat the rest of the duct as a t ube that moves 
digestive juice. In our model therefore, the acinus is represented by two vectors of numbers. The 
  11 
first vector, named "status", carries numbers that describe the acinus status. The very first 
component of the “status” vector corresponds to the status of the acinus itself. It has two values 0 
or 1, m eaning dead or alive respectively. The second component of the “status” vector is 
responsible for describing whether the acinus has been regenerated or not, coded as 1 or  0 
respectively. The third, final, component represents the number of acinar cells in a particular 
acinus. For example, a newly created acinus would have the following three numbers in “status” 
vector: {1,0,100}, meaning that the acinus is alive, was never regenerated, and has 100 acinar 
cells. The second vector, named "lumen", contains a set of variables that correspond to levels of 
trypsinogen, PSTI, calcium, and bicarbonate in the lumen. In order to simulate the secretion 
work of acinar cells and duct cell we designed two separate functions. In general it works like 
this: in the beginning we read the “status” vector. If the acinus is alive, we call the acinar cell 
function once for each acinar cell in the particular acinus. Then we finish our series by calling 
the duct cellfunction. Every time we call the acinar cell function we collect the produced 
molecules to the second vector, which at the end gives us the sum of each of the secreted 
molecules. 
The way we define theacinus allows us to represent the whole pancreas in a matrix 
(Figure 3B), where each cell of the matrix corresponds to a single acinus.We can also mimic 
branching system of the pancreas. We treat the left column as a main duct andindividual rows as 
branches of the main duct. So we collect secreted juice in a particular direction: from right to left 
in every row and up in the left column. If we want to be more precise, we could even distinguish 
different parts of the pancreas. For example,we could assign the first few rows to the head of the 
pancreas, the next few rows to the neck, and the rest of the rows to the body and tail of the 
pancreas. Furthermore, we could treat the first row as the Santorini duct that opens to the 
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duodenum separately from the main duct. This representation of the pancreas even allows us to 
simulate duct obstruction that would immediately eliminate a portion of the pancreatic acini from 
delivering enzymes to the intestine. For this purpose it would be enough to define a single cell of 
the matrix as obstruction point and stop collecting pancreatic juice from the acini that are located 
after the obstruction point.  
 
Figure 3.Diagram of the pancreas. 
A) Diagram of the pancreas.Copied from http://en.wikipedia.org/wiki/File:Duodenumandpancreas.jpg30; 
B) Scheme used in the model to describe pancreas; 
2.1.3 Mutations 
We are interested in three potentially mutated genes: the cationic trypsinogen gene (PRSS1), the 
pancreatic trypsin inhibitor gene (PSTI), andthe cystic fibrosis transmembrane conductance 
regulator gene (CFTR). In order to include mutations in the model, we create a set of variables 
that will be included at key points of the model. For example, PRSS1 gene mutations can alter 
  13 
production of trypsinogen, its activation, and degradation of active trypsin. The most common 
PRSS1 mutations are R122H and N29I. The R122H mutation increases trypsin resistance to 
autolysis and permanent inactivation,while the N29I mutation alters the structural conformation 
of trypsinogen that makes it tolerant to trypsin inhibitor15-17. For PSTI gene mutations we 
distinguish between the production rate of PSTI and its capability to bind active trypsin. For 
simplicity we can make an assumption that all PSTI binds to active trypsin (which is fairly well 
justified since the production of PSTI is typically much less than that of trypsinogen). This 
allows us to calibrate the binding rate of PSTI to trypsin with the production rate of PSTI (the 
less produced, the less bound). Lastly, for CFTR mutations, we are interested only in its effect 
that reduces bicarbonate production. In order to include these rates in the model we create five 
variables, such as trypsinogen production (Tg_p), trypsinogen activation (Tg_a), trypsin 
inactivation (T_i), PSTI production (PSTI_p), and CFTR mutation (CF). We assign them a value 
between 0 and 1 and include them in our equations. The default value for these rates is typically 
1, and we consider only reduced rates, e.g., values less than 1. When these parameters are equal 
to 1, they have no effect. But once we decrease them they gain influence. For example, Tg_p is 
included in equation that describes trypsinogen production. Lets say that normally 100 molecules 
of trypsinogen are produced. When Tg_p is 1, we get all 100 molecules of trypsinogen, but if we 
reduce Tg_p to 0.90, we will get only 90 molecules of trypsinogen instead. The same rule applies 
for the rest of parameters in this set. If this approach is proved to be useful we could treat any 
mutation as a series of these rates and build a library of known mutations.  
  14 
2.1.4 Inflammation 
Inflammation (I) is a protective mechanism against defection, but may also cause injury (cell 
death in our case). It is recognized as a type of nonspecific innate immune response to injury. 
The main purpose of inflammation is to remove infectious agents and initiate healing. 
Technically, inflammation is the complex process that directs immune system components to 
migrate to the site of injury and do their work31, 32. In our model we are interested only in a few 
aspects of inflammation like causation, duration time and its effects. We describe inflammation, 
as a v ariable that takes values from 1 t o 2, w here 1 m eans no i nflammation and 2 m eans the 
highest level of inflammation.We assume that inflammation can increase suddenly, in our case 
during a day, but reduces gradually, which means it takes few days for inflammation to 
disappear. We wrote two functions that either increase or decrease inflammation. Every time we 
call the increasing function we add 0.5 uni ts to inflammation and every time we call the 
decreasing function we subtract 0.05 unitsfrom inflammation (Figure 4). In the model we 
distinguish two levels of inflammation, a local level that corresponds to inflammation of a single 
acinus and consequently influencesthe acinar cells of the acinus, and a g eneral level that 
corresponds to inflammation of the whole pancreas. For general inflammation we also have a 
threshold equal to 1.55. Whenever general inflammation is increased twice in a short period of 
time, it reaches or pushes over the threshold and we call this an attack of the pancreatitis. In the 
model cell death and trypsin overactivation arethe only stimuli that can increase inflammation. 
Once inflammation is increased it w ill affect key points in the model like increasing PSTI 
production and increasing trypsinogen activation both in the acinar cell and in the lumen16, 19, 20. 
Without further injury or cell death, inflammation is expected to go down slowly. We designed 
this model so that inflammation isreduced only if there is no cell death at all during the 
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simulatedday, meaning no damage has occurred. Currently we do not distinguish between acute 
and chronic inflammation. However, we could make inflammation variable more flexible in 
order to capture the differences between acute and chronic pancreatitis, if our approach is proven 
to be useful. 
 
 
  Figure 4. Inflammation. 
We describe inflammation, as a variable that takes values from 1 to 2, where 1 means no inflammation and 2 means 
the highest level of inflammation. We can either increase inflammation by0.5 units in the case of damage or 
decrease it by0.05 units in the case of no damage. Whenever general inflammation reaches or pushes over the 
threshold (1.55) we call it a pancreatitis attack. 
2.2 PROGRAMMING 
2.2.1 Parameters used 
We store parameters in a separate text file in order to keep the model flexible. If we want to run 
the simulation with a different set of parameters, we simply need to modify the text file that 
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contains these parameters, but not the program itself. The parameters and their shortcuts used in 
the model are listed in theTable 2. First we specify the number of patients and the number of 
days that we want to follow each patient. Then we define the size of the pancreas by providing 
numbers of branches of the main and secondary ducts along with the number of acinar cells that 
each acinus contains. 
The next set of parameters describes the molecules that we are interested in, they are as 
follows: trypsinogen, PSTI (secretory trypsin inhibitor), calcium, bicarbonate, and water. It is 
important to understand that numbers assigned to trypsinogen and PSTI represent their total 
amount of produced molecules by the acinar cell. The parameter for calcium isa rate that calcium 
level increases when digestive enzymes go from acinar cell to lumen, and from lumen to main 
duct. Water has similar meaning calcium in this set of parameters. It describes increased water 
level in the main duct compared to the lumen of the acinus. The final parameter in this set 
corresponds to the bicarbonate secreted by the duct cells. 
The next set of parameters is designed to modify all the equations we used in the model. 
They are: trypsinogen production, trypsinogen activation, trypsin inactivation, PSTI production, 
and CFTR mutation. Thisparameters of this set are multipliers in different parts of the equations 
we wanted to modify. When these parameters are equal to 1, they have no effect. But once we 
increase or decrease them, they gain influence. For example, Tg_p is included in equation that 
describes trypsinogen production. Let us say that normally 100 m olecules of trypsinogen are 
produced. When Tg_p is 1, we get all 100 molecules of trypsinogen, but if we reduce Tg_p to 
0.90 we will get only 90 molecules of trypsinogen instead. The same rule applies for the rest of 
the parameters in this set. 
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The next set of parameters defines the variability used in the model. We have three 
compartments of the model where trypsin can be activated. They are the acinar cell, the lumen 
and the duct respectively. For each compartment we specify the percentage of existing 
trypsinogen to be activated. We named these numbers as CA, LA, and DA. It is important to 
mention that C++ is case sensitive33, so CA and Ca are distinguished from each other. We also 
specify a molecule “range”, the range within which the production of any molecule can vary. We 
use this parameter to introduce random noise to molecule production. For example, if we specify 
trypsinogen production as 100 molecules,after we add random noise, trypsinogen can take any 
value between 95 to 105 molecules. 
Finally the last parameter (Thr) definesthe tolerance of the acinar cell to the damage 
caused by trypsin. Whenever the level of trypsin molecules that were not blocked by PSTI 
exceeds this threshold, we assume that the acinar cell has been so damagedthat it is no longer 
able to recover and so is destroyed. 
Since this is a preliminary model of pancreatitis we agreed to take one set of parameters 
that gives a good-looking survival curve and use it as a reference. We didn’t expect our reference 
survival curve to be an exact match to any existing data, but to have curves for the three attacks 
located in the middle of the graph and we wanted the three curves to be spread out enough from 
each other so that variations between them can be observed (Figure 5). 
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Figure 5.Reference survival curve of the pancreatitis. 
Survival curve of the first pancreatitis attack with 99% confidence intervals (left graph); 
Survival curves for first, second, and third attacks of pancreatitis respectively (right graph) 
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Table 2. Parameters used in the model. 
Parameter Symbol Value 
Number of patients NP 100 
Number of days ND 11000 
Number of main ducts D1 30 
Number of secondary ducts D2 30 
Number of acinar cells D3 100 
Trypsinogen  TG 100 
PSTI P 20 
Calcium Ca 5 
Bicarbonate BC 1 
Water W 5.5 
Trypsinogen production Tg_p 1 
Trypsinogen activation Tg_a 1 
Trypsin inactivation T_i 1 
PSTI production P_p 1 
CFTR mutation CF 1 
Trypsin activation in the cell CA 0.053 
Trypsin activation in the lumen LA 0.03 
Trypsin activation in the duct DA 0.03 
Molecule range MR 0.1 
Threshold for inflammation Thr 4.832 
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2.2.2 Building the framework 
The first step in the program is to create a 30x30 matrix. Each cell of the matrix corresponds to a 
single acinus that contains 100 acinar cells and a d uct cell. The size of the pancreas, and the 
number of branches that ducts have, varies from person to person. Textbooks provide us only 
with approximate ranges of those numbers, from 20 to 40 branches for main duct and the same 
range for secondary ducts1-3. So we decided to create a matrix that corresponds to the 
averageexpected size of the pancreas. 
2.2.3 Pancreas stimulation 
Secretion of trypsinogen and its flushing into the intestine is a continuous process.Conversion 
from trypsinogen into active trypsin can occur at any time during this process. In order to 
simplify our model we decided to separate this process into three major domains (stages): inside 
the cell,in the lumen, and in the duct. This division was guided by the fact that activation of 
trypsinogen can occur either when it is still inside the cell or outside the cell when it was secreted 
to the lumen or during transportation though the duct16-20. 
2.2.3.1 Acinar cell stimulations 
In response to food intake first we stimulate acinar cells to produce trypsinogen, PSTI, 
andcalcium. The real-world production rates of these molecules are unknown, thatis why we 
decided to create them ourselves, but keep them proportional to each other. The levels of 
trypsinogen and PSTI molecules are assigned according to parameters predefined in the external 
control file. Suppose we synthesize100molecules of trypsinogen while synthesizing only 20 
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molecules of PSTI. We are not interested in the exact amount of secreted calcium, but in the rate 
it increases as it goes from the acinar cell to the lumen and from the lumen to the main duct. So 
on this level of the acinar cell we assign 1 to the calcium. We also introduce a random variability 
by applying the function that alters the molecule levels. Furthermore, we include parts that 
modify trypsinogen and PSTI production rates in order to give means to model effects of 
mutations. 
Tg = (100 + random noise) * (trypsinogen production); 
PSTI = (20 + random noise) * Inflammation^2 * (PSTI production); 
Ca = (1 + random noise) *(1+(Inflammation-1)/2); 
We modeled PSTI and calcium as inflammation-dependent variables. However, if we 
apply the same influence of inflammation on both PSTI and calcium, this effect will be canceled 
during further simulation, when we convert some trypsinogen into active trypsin. Since we 
believe that the main role of inflammation is to reduce damage, we modeled the PSTI responses 
to the increased inflammation exponentially, whilecalcium responseslinearly.  
2.2.3.2 Duct cell stimulation 
The next step is to stimulate duct cells to produce bicarbonate. We are not interested in exact 
amount of bicarbonate secreted, but in the influence it has on t he water. For the sake of 
simplicity we assign 1 to the bicarbonate level and add some random noise. We included 
bicarbonate in the water secretion in linear manner. So it s tarts lowering water secretion when 
bicarbonate value becomes less than 1: 
BC = (1+random noise)  
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2.2.3.3 Activation of Trypsinogen 
We modeled three levels of trypsinogen activation (inside the acinar cell, in the lumen, and in the 
main duct). For these three cases we created three separate functions that activate some portion 
of trypsinogen into trypsin and check whether the existing PSTI molecules are numerous enough 
to stop damage. The percentage (p) of trypsinogen activated in the acinar cell, the lumen, and the 
duct are specified in the external file with the rest of model parameters and they named as CA, 
LA, and DA respectively. We also applied a function that brings randomness to these 
percentages as well. For example, if CA=5.3%, after we introduce randomness it takes any value 
from 0 to 5.3% with a uniform distribution (In the equation below, we notate this as 
‘(0<p<CA)’). We also have the function that makes sure that calcium influences trypsin 
activation only in the presence of inflammation34, 35. This function is called “cum” and takes two 
values inflammation and calcium respectively. It returns value 1 when there is no inflammation 
and inflammation times calcium when there is inflammation. Finally we included parts that 
modify trypsin activation in order to give the means to model effects of mutations. They are 
trypsinogen activation (Tg_a) and trypsin inactivation (T_i) respectively. The equations used to 
activate trypsin in the lumen and duct are identical, however they give different results. The 
reason of this difference is that before trypsin activation in the duct, we divided the trypsinogen, 
PSTI and calcium levels by the water level in order to mimic dilution. 
We think of acinar cell as a system that has other means of resistance to damage from 
active trypsin besides PSTI. In order to model this resistance we first subtract PSTI from 
trypsinogen, then apply modifying factors for trypsin activation and check whether activated 
trypsin exceeds a certain threshold. If it exceeds the threshold we destroy the acinar cell, 
otherwise the acinar cell secretes the produced molecules to the lumen. In the lumen and the duct 
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we again activate some portion of trypsinogen and check whether existing PSTI molecules are 
enough to stop damage. So the equations we used in the simulation are listed below. 
 
In the acinar cell: 
T = (TG-PSTI) * (0<p<CA) * cum(Inflammation, Ca) * Tg_a / T_i 
In the lumen: 
T = TG * (0<p<LA) * cum(Inflammation, Ca) * Tg_a / T_i 
In the duct 
T = TG * (0<p<DA) * cum(Inflammation, Ca) * Tg_a / T_i 
2.2.3.4 Pancreas growth and recovery 
Experiments with mice and rates have shown that the pancreas has incredible power to 
regenerate. It was shown that pancreatic cells could go through temporary dedifferentiation, 
undergo proliferation and then again differentiate into the cells of their own,meaning that the 
acinar cells give rise to the pool of acinar cells and the duct cells give rise to the pool of duct 
cells36. In severe cases like partial pancreatectomy, it is the duct cells that are responsible for 
recovery of the whole pancreas37. They undergo through temporary dedifferentiation, 
proliferation, and differentiation, but this time they are not limited to a single cell type, but are 
able to supply all types of pancreatic cells. However, certain conditions like chronic 
inflammation or chronic and heavy alcohol exposure can severely limit the recovery capacity9, 14. 
In order to reserve the means to model these conditions and prevent immortality of the pancreas 
we limit the number of recoveries of the acinus, but not the recovery of the acinar cells. In the 
model it lo oks like this:every day of simulation we run a special function that checks two 
checkpoints: the number of the acinar cells in every acinus and the total number of living acini. 
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1. When the number of cells has reduced to less than half of the initial number, we 
increase the number of cells to normal (acinar cell recovery). 
2. The second checkpoint checks whether the total number of acini is severely 
reduced. If it is reduced too much from its original value, we regenerate the 
pancreas by converting dead acini into living, but only once: an acinus is only 
revivedif it was never regenerated before. In the case of successful recovery we 
assign the inflammation status of the acinus equal to the general inflammation 
status and thesecond number of “status” vector takes value of 1, indicatingthat the 
recovery of the acinus has occurred. This indicator is made in order to prevent 
the“immortality” of the pancreas. It also leaves room to add activation of the 
sartoliny cells in the future to simulate fibrosis. 
2.2.4 Stimulation flow chart 
The stimulation of the model has three levels. First we stimulate the matrix, then the acinus, and 
finally the acinar cell. However collection of the digestive enzymes goes in the opposite 
direction. The acinar cell produces digestive enzymes to the acinus and then they are collected to 
the duct (matrix) (Figure 6). Once acinar cell is stimulated it produces three types of molecules, 
such as trypsinogen, PSTI, and calcium. In our model we associate the acinar cell with the 
function that creates a vector of six numbers. The first four numbers correspond to molecules 
that both acinar and duct cells produce, the last two numbers correspond to water and the 
inflammation variables respectively. In the diagram below we keep track of only five of the 
numbers, because they correspond to molecules that pass through the levels. The sixth number is 
kept in mind, because it corresponds to inflammation, which is a local variable. When we call the 
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function that stimulates acinar cells we use parameters that were defined from the beginning of 
the simulation. For all five molecules we also apply the function that add some random noise to 
each of the numbers. For example, let’s assign the following number of molecules {TG, P, Ca, 
BC, W} ={100, 20, 1, 0, 0} for trypsinogen, PSTI, calcium, bicarbonate, and water respectively. 
The inflammation variable takes on a value equal to the inflammation of the acinus. In this 
example for simplicity we will skip the function that adds random noise. After we assign values 
for the molecules, we convert some of the trypsinogen into active trypsin and check whether 
there are enough existing PSTI molecules to block active trypsin and stop damage. If there are 
not enough PSTI molecules, then we assume that the acinar cell experienced severe damage and 
so destroy the cell. This will lead to an increase in local inflammation. In the case when number 
of PSTI molecules exceeds activated trypsin, we reduce the number of trypsinogen and PSTI 
molecules by thenumber of activated trypsin. Then this vector is added to another vector that 
corresponds to the lumen of the acinus. To continue our illustrative example (Figure 7), suppose 
that 5 trypsinogen molecules were converted into trypsin. Since we have more than enough PSTI 
molecules (20), we reduce both trypsinogen and PSTI molecules by 5. So after trypsinogen 
activation the vector will contain the following numbers {95,15,1,0,0}, which then goes to the 
lumen. Suppose that we are able to successfully stimulate the acinar cell n times. That would 
mean that the acinus will have n times more molecules than a single acinar cell can produce and 
the lumen vector will look like {95n,15n,n,0,0}. At this point we let the duct cell produce 
bicarbonate and temporarily assign 1 to the water, so the vector would look like {95n,15n,n,1,1}. 
Then we increase the level of water in order to mimic increased volume ofpancreatic juice due to 
the secretion of bicarbonate by the duct cells. Suppose water was increased 5.5 times. It would 
also mean that all other molecules were diluted 5.5 times and the final vector would look like 
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{17.27n, 2.73n, 0.18n, 0.18, 1}. T hen we change the calcium level in order to mimic difference 
in the calcium level between the acinar cell and the lumen. Suppose the calcium level increased 5 
times, so the lumen vector would be as {17.27n, 2.73n, 0.9n, 0.18, 1}. A fter increasing both 
water and calcium levels we again convert some amount of trypsinogen into trypsin and check 
whether active trypsin was successfully inhibited. If the acinus is destroyed, we increase general 
inflammation that corresponds to inflammation of the whole pancreas. In the case of successful 
acinus stimulation we collect pancreatic juice into the duct. If the number of the successful 
acinus stimulations were“m”, then the duct would have “m” times more molecules compared to 
the amount that a single acinus can produce and the duct vector would be as {17.27nm, 2.73nm, 
0.9nm, 0.18m, m}. At the level of duct we again increase the level of calcium in order to mimic 
the difference in the calcium levels between the lumen and the main duct. Suppose we again 
increased calcium level 5 times, so duct vector would look like {17.27nm, 2.73nm, 4.5nm, 
0.18m, m}. At this point we convert some amount of trypsinogen for the last time. Then we 
check whether there are enough remaining PSTI molecules to avoid damage. In the case of 
damage we increase the general inflammation. In case of successful stimulation of the matrix we 
simply clear the duct vector, because it has no further use. Note that inflammation is increased 
only once in each level of stimulation per day of simulation. This means that even if more than 
one acinar cell was destroyed, the local (acinus) inflammation would be increased only once at a 
single day of the simulation. A similar rule applies for general inflammation - it is increased only 
once for any number of destroyed acini. We made this simplification because at the current stage 
we don’t know exactly how inflammation depends on the number of dead acinar cells or acini. 
That is why we trigger inflammation when at least one acinar cell or acinus dies and increase 
inflammation again the next day of simulation, if one or more acinar cells or acini die. 
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Figure 6.Simulation flowchart. 
Tg – trypsinogen; PSTI - pancreatic secretory trypsin inhibitor; Ca – calcium; BC – bicarbonate; W – water; T – 
trypsin activation; n – number of successfully activated acinar cells; m – number of successfully activated acini; 
2.2.5 Overall simulation flow chart 
The overall simulation starts with specifying the parameters of the model (Figure 7). Parameters 
that are read from external file are listed in Table 2. After the program successfully readsthe 
parameters, it creates a matrix, where the number of rows corresponds to the number of main 
duct branches and the number of columns corresponds to the number of secondary duct 
branches. Each cell of the matrix is turned into an acinus and set for further stimulations. Then 
the whole matrix is synchronized for inflammation. In this step we make sure that none of acinus 
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(local) inflammations is less than pancreatic (general) inflammation. We thought that whenever 
local inflammation increases it may or may not affect general inflammation. But once general 
inflammation increases it always affects every local inflammation. We also check the size of the 
pancreas and apply recovery processes when either of the numbers of the acini or the acinar cells 
dramatically drops down. For each patient we create the pancreas that is full size and has no 
inflammation, that is why we skipped the synchronization and recovery for the first day of the 
simulation. After synchronization and recovery step, we actually stimulate the pancreas. The 
stimulation is passed from the pancreas to every living acinus and then to every living acinar 
cell. In each step of the stimulation damage can occur. Depending on a scale of the damage we 
increase either local or general inflammation. If general inflammation increases above certain 
threshold we call it a s an acute pancreatitisattack. We record the day and number of the 
pancreatitis attack for future output. We follow patients for a maximum of three pancreatitis 
attacks. So after the third pancreatitis attack or patient’s death we stop the simulation for the 
current patient. If the conditions to stop the simulation are not met, we continue the simulation 
by collecting pancreatic juice. In the case of no damage during the simulation we reduce both 
local and general inflammations. At this point we loop the simulation to the point when we 
synchronize pancreas for inflammation and performrecovery and continue repeating stimulations 
as many times as the number of days defined in the parameters. After we have run the simulation 
for the specified number of days or have disruptedthe simulation due to any other reason, we 
stop the simulation and repeat it f or the next patient starting from creating a new pancreas 
(matrix). 
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Figure 7.Overall simulation flowchart. 
A – acini; AC – acinar cell; 
2.2.6 Statistical analysis 
In our model we simulated 100 patients. For each patient we recorded three time points that 
corresponded to the times of the first, the second and the third attacks of pancreatitis. For those 
patients who never had any attacks of pancreatitis, these time points were right censored. We 
used Kaplan-Meier estimator to estimate survival function of not developing the first, the second 
and the third attacks of pancreatitis respectively.Survival curves from different sets of the 
parameters were compared against the reference survival curve using the G-rho family of tests. 
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2.2.7 Software 
The simulation model itself was written in C++ using Xcode Version 3.2.2. The simulations 
themselves were run on our Gattaca cluster. Output data were then processed using R 2.11.1. 
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3.0  RESULTS 
3.1 WORKING PARAMETERS 
In our simulations, we tested working parameters in a set of 100 patients with 11,000 days follow 
up. There was no difference in terms of the structure and size of the simulated pancreas itself. 
Each time the created matrix was 30x30, which represents a pancreas with 30 branches of the 
main duct and 30 branches of the secondary ducts. Every cell of the matrix represented a single 
acinus with 100 acinar cells. 
Ideally when the model is built, the most appropriate way to test it is to turn on and off 
different parts of the model and see how such actions influence on the general behavior of the 
model. In the current work we useda stochastic approach that brings some degree of expected 
variability to the behavior of the model. Without knowing this variability it would be hard to 
explain changes in the model’s behavior, whether they are due to modifications in the model or 
due to random chance. For this purpose we tried to find out the range within which each of the 
parameters can vary (Table 3). In order to test variability due to random chance we run our 
simulations with the same working parameters 33 t imes. The survival curve for the first 
pancreatitis attack from the first simulation was set as a reference survival curve. The rest of the 
survival curves from 32 additional simulations were then compared to the reference one. None of 
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the additional simulations resulted in survival curves that significantly differed from the 
reference one with an alpha level of 0.01. 
The results in Table 3were obtained using the original code of the program (Appendix 
A). Later, the code of the program was revised according to the comments of the members of the 
defense committee. The modified program code can be found in the Appendix B; it was this 
revised code that was described in the previous sections. The changes that were made in the 
program code are explained in the following discussion section (4.3.1). 
Using the original code in Appendix A, we started our simulation with the total amount 
of produced trypsinogen molecules as 100. T hen to assess sensitivity to the initial parameter 
values, we ran a series of simulations with a g rid of alternate values of produced trypsinogen 
molecules while keeping the rest of the parameters constant. We found that trypsinogen can 
change from 99.94 to 100.01 without causing a statistically significant difference in thesurvival 
curve of pancreatitis compared to that obtained with the initial set of the parameters. The 
comparisons of survival curves were made using an alpha level of 0.01. The same procedure was 
applied to the rest of the parameters. As suggested before we took a total amount of PSTI equal 
to 20% of total trypsinogen, which gives us 20 molecules of PSTI. Further simulations showed 
that this parameter could vary within a small range from 19.99 to 20.06 without causing 
statistically significant differences in the survival curve of the pancreatitis. The next parameter 
we tested is the rate at which calcium level increases while enzymes move from acinar cells to 
the lumen and then from the lumen to the main duct. We took the initial rate of this variable to be 
equal to 5. The initial value of calcium inside the acinar cell was taken as 1 molecule, then it 
increases 5 times in the lumen and again 5 times in the main duct. We have discovered that this 
rate was able to vary within a small range from 4.98 t o 5.01 without causing any statistically 
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significant changes. We started with an initial bicarbonate level as 1 molecule, but found that the 
range within which the level of bicarbonate can range is rather large. We found that bicarbonate 
can be as low as 0.7 and as high as 1.25 and still produce survival curves almost identical to 
those obtained with the initial set of parameters, suggesting that the level of bicarbonate may go 
even lower and higher than we tested. The next parameter we tested was water production rate. 
Initially we took it to be equal to 5.5 and found that its lowest value (equal to 4.4), but not the 
highest value. Water level can go as high as 800 and yet doesnot cause any significant changes in 
the survival curve of the pancreatitis.  
The set of parameters responsible for mutations that alter production rates of trypsinogen, 
PSTI, and water (through bicarbonate production) were initially set equal to 1. A  series of 
simulations showed that trypsinogen production rate is very sensitive to any changes, even the 
slightest change as ± 0.001 resulted in significant difference from initial survival curve of the 
pancreatitis. Both trypsinogen activation and trypsin inactivation rates are also very sensitive; 
they range from .9995 to 1.0005. PSTI production rate can be as low as 0.9995, but higher than 
1.003. The last parameter of mutations that corresponds to the CFTR mutation didnot show any 
strict borders - it could take values lower than 0.35 and higher than 1.06.  
The next three parameters have been taken to represent the activation rate of the 
trypsinogen in the acinar cell (CA), the lumen (LA) and the duct (DA) with initial values 0.053, 
0.03, and 0.03 (or 5.3%, 3%, and 3%) respectively. It seems that CA is the most sensitive among 
all three parameters. It can take value as low as 0.05294, but not greater than 0.05301, which 
means that even a small increase of this value by 1e-5 results in significant difference in the 
survival curve of the pancreatitis. LA is less sensitive to changes and can vary by ± 2e-4. DA is 
the least sensitive to changes. It can be lower than 0.024 and higher than 0.036. The next 
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parameter is MR, the range within which such parameters like trypsinogen, PSTI, calcium, and 
bicarbonate can vary. Initially it was taken to be equal to 0.1 (or 10%) and it could take values as 
low as 0.0996, but  not greater than 0.1001. The final parameter that was tested is Thr, the 
threshold for active trypsin that can result in the acinar cell death. Initially this value was set to 
4.832, and it can vary from 4.8308 to 4.8359. 
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Table 3. Working parameters. 
Parameter Symbol Value Range 
Number of patients NP 100 - 
Number of days ND 11000 - 
Number of main ducts D1 30 - 
Number of secondary ducts D2 30 - 
Number of acinar cells D3 100 - 
Trypsinogen TG 100 99.94-100.01 
PSTI P 20 19.99-20.06 
Calcium Ca 5 4.98-5.01 
Bicarbonate BC 1 <0.7->1.25 
Water W 5.5 4.44->800 
Trypsinogen production Tg_p 1 >0.999-<1.001 
Trypsinogen activation Tg_a 1 0.9995-1.0005 
Trypsin inactivation T_i 1 >0.9995-1.0005 
PSTI production P_p 1 0.9995->1.003 
CFTR mutation CF 1 <0.35->1.06 
Trypsin activation in the cell CA 0.053 0.05294-<0.05301 
Trypsin activation in the lumen LA 0.03 0.0298-0.0302 
Trypsin activation in the duct DA 0.03 <0.024->0.036 
Molecule range MR 0.1 0.0996-<0.1001 
Threshold for inflammation Thr 4.832 4.8308-4.8359 
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4.0  DISCUSSION 
4.1 WORKING PARAMETERS 
After we run our simulations and tested working parameters, we found several points that we 
would like to change. We made few modifications in the program code in order to eliminate 
these questions. These modifications didn’t change overall results of the simulations and are 
explained more detailed in the discussion part (4.3.1). In this work we present working 
parameters and their discussion using original program code of the model (Appendix A). 
The first step of testing our simulation model was to figure out working parameters 
(i.e.,are theparameters that give us a s table survival curve of the pancreatitis). Initially the idea 
was to adjust these parameters to existing statistical data of pancreatitis in the general population. 
But this task seemed to be very tricky. Two issues that we faced in our simulation werethe time 
required to run the simulation and lack of statistical data about the pancreatitis in the general 
population. 
Our mathematical model was designed such that you need to specify the number of 
patients and the total amount of days you want to follow each patient. The model simulates one 
patient at a time for the specified numbers of days or until three pancreatitis attacks occur and 
then repeats the same simulation for the next patient with the same parameters. The size of the 
matrix we created for the pancreas simulation was also important. Depending on the number of 
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the acini and the acinar cells that a s ingle acinus contains, the time required for simulation 
changed dramatically. The “bigger” the pancreas (i.e., the larger the matrix), the more time the 
simulation took. In order to save time and still be able to keep the modeling parameters large 
enough to represent an entire population we decided to simulate 100 pa tients for 11,000 days 
(~30 years) follow up. We also agreed to use a matrix size equal to 30x30, meaning 30 main duct 
branches and 30 secondary duct branches or 900 acini in total. Each acinus had 100 acinar cells, 
for a total of 90,000 acinar cells in the pancreas. Even with these modest restrictions,a powerful 
computer resource, called “The Gattaca Cluster”, took about 10 hours to make one simulation. 
Due to the architecture of The Gattaca Cluster we were able to submit the model multiple times 
simultaneously using one processor per a job.We submitted the model 13 times simultaneously 
with different sets of parameters. A single run of the model takes about 10 hours, by submitting 
the job in parallel we were able to run the model 13 timesand spendonly time required for one 
run. 
The availability of existing descriptive data was our second main concern. Since our 
primary outcome was a measure of the survival function of the pancreatitis in the population, our 
best choice was to apply statistical methods for survival analysis to our output data from the 
simulation. In order to fit our model to existing data we needed to find statistics for incidence of 
pancreatitis from a cohort study with as long a follow up as possible, to get a measure of how 
frequent a second or third attack is in the same patient. When we were first designing this model 
we couldnot find any data that matched our criteria, though we continue to search for suitable 
data sets, and hope to get usable data from Dr. Whitcomb’s North American Pancreatitis Study 
(NAPS2). Since this is a preliminary model of pancreatitis we agreed to take one set of 
parameters and use the resulting survival curve from this set as a reference survival curve. We 
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didn’t expect our reference survival curve to be an exact match to any existing data, but to have 
curves for the three attacks of pancreatitis located in the middle of the graph and spread out 
enough from each other so that variations between them can be observed (Figure 6). If we take 
too small an incidence rate for pancreatitis, we would probably have had to simulate hundreds of 
thousands of patients in order to collect enough patients with even a first attack of pancreatitis, 
since the incidence rate for acute pancreatitis is 17 per 100,000 people. There also will be limited 
space if we try modeling protective effects of some of the parameters. 
 
 
4.2 SENSITIVITY OF THE PARAMETERS 
Once we achieved a desired survival curve, we used the resulting set of parameters as a reference 
for further simulations. All further simulations were obtained using the original program code. In 
order to test variability due to random chance we run our simulations with the same working 
parameters 32 additional times. Obtained survival curves were then compared to the reference 
one. None of the additional simulations resulted in survival curves that significantly differed 
from the reference one with an alpha level of 0.01.  
Once we settled on w orking parameters, we tried to find the range within which the 
parameters can change and yet not cause statistical deviations from the reference curve. We 
made a series of simulations where we changed a single parameter at a time, while keeping the 
rest of the parameters constant. Changes in most of the parameters had a large effect on the 
resulting survival curves, suggesting the simulation was highly dependent on t he values we 
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picked for those variables. Some of the ranges in which changes did not have an effect were not 
symmetrical when compared against the reference values. That is, the lower and upper 
boundaries were not equidistance from the reference (initial) value. I presume this kind of 
asymmetry can be explained by the variability of the model itself. For the same reason we 
couldnot find exact boundaries of some parameters. For example, trypsinogen production had an 
initial value equal to 1 a nd even slightest changes (such as ± 0.001) resulted in significant 
departures from the reference survival curves. 
The opposite situation was seen with three parameters: bicarbonate, water, and CFTR 
mutations. They could vary significantly without causing any significant difference in the 
survival curve. We couldnot even find boundary values for these parameters. It didnot matter 
how much we changed them, they seemed to have no effect on the outcome. The explanation of 
tolerance to such variability lies in the way we used water in the model.It happened because 
activated trypsin was reverse proportional to water. The more water we had, the less trypsin had 
been activated.  
4.3 FUTURE DEVELOPMENT 
4.3.1 Modification applied to the program code 
In the initial version of the program code (Appendix A) we had divided the molecules in the 
lumen to the number of successfully worked acinar cells. This division was made in order to 
average produced molecules in every acinus. In the revised version of the program code 
(Appendix B) we did not apply this averaging. The revised version of the program gave the same 
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results as original version and the reason why removing of the averaging did notalter results 
because it did not change proportion between trypsinogen and PSTI in the lumen, but added one 
extra operation in the calculations. 
Initially we modeled that the acinar cell could produce chloride that had influencedthe 
water production through bicarbonate in the lumen. We simplified bicarbonate production and 
made the water production directly dependent on chloride. However after revising this concept 
we decided to rename chloride as bicarbonate and move bicarbonate production out of the acinar 
cell function to the duct cell function. This change in the program code also didnot alter the 
outcome of the simulation. When chloride was produced by the acinar cell, it was then averaged 
in the lumen, which means that the variability of chloride was narrowed down. In the revised 
version of the program code we produce bicarbonate only once in the lumen, so the variability of 
bicarbonate remained greater than if it was produced by the acinar cell and then averaged in the 
lumen. If we remember that water could vary within a very big range without causing any 
departures in the outcome of the simulation, we think that the water variability is enough to 
compensate increased bicarbonate variability. 
A final modification was made in the function that activates some portion of trypsinogen 
in the main duct. We used following formula to activate trypsinogen: 
T = TG * (0<p<DA) * cum(Inflammation, Ca) * Tg_a / (T_i*Water) 
and then compared activated trypsin (T) with existing PSTI molecules. In this formula we 
divided trypsin to water to mimic dilution of the pancreatic juice in the main duct. We assumed 
that water variable should appear in the above formula of trypsin activation twice. It should come 
with trypsinogen and calcium variables because both of then supposed to be divided to water in 
the main duct. In this case we also shoulddivide PSTI to water before comparing it to activated 
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trypsin. But when trypsin was compared to PSTI, one division to water could be canceled 
leaving only one division to water in the formula of trypsin activation. However this assumption 
turned out to be wrong because we forgot that the “cum” function returns 1 in the case of no 
inflammation and inflammation times calcium in the case of any inflammation. This means that 
the water variableis not canceled out as originally assumed. So in the revised version of the 
program code we dilute the pancreatic juice before activating trypsin in the main duct. As we 
expected this change in the program code did not alter working parameters, except those 
parametersthat describe trypsin activation, they are CA, LA, and DA. After testing a r evised 
version of the model, we noticed that the amount of trypsinogen activated in the acinar cell (CA) 
appears to be the most important parameter among these three parameters mentioned above. 
With CA equal to 0.052566(± 2e-6) we could obtain a survival curve similar to the reference 
survival curve. The value of other two parameters (LA and DA) remained at the same level as in 
the initial version of the model (0.03 and 0.03 respectively). 
4.3.2 The curve becomes stable after 500th week 
We have never observed a change in the survival curve after the 500th week (3500 days) of 
simulation. This is also true for the rate of second and third attacks of pancreatitis. This behavior 
of the resulting survival curves remained the same even after we modified the programming 
code. One could say that there is no need to run the simulation for 11,000 days and wait 10 hours 
when you can run the simulation only 3,500 days and get the same results. More importantly that 
could reduce the time required to run simulation. This might be true at the moment, but what is 
the real reason behind this behavior? It is definitely in the way the model was designed. 
Debugging this question would require following changes of the model’s parameters day by day 
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and analyzing their behavior. For this purpose we modified the program, such that in the new 
version we get an output of a set of parameters (general inflammation, total number of acini and 
acinar cells) each day so we could follow their changes in real time. This has not yet revealed the 
cause of the lack of changes after 500 weeks, but we continue to investigate the issue.  
4.3.3 Parallelize simulation 
A complete run of the model that includes a single set of parameters and 100 pa tients takes 
roughly 10 hours. The modifications we made to the program code were not directed to solve 
this time issue, so remains in the revised program code. Due to the fact that all cases of 
pancreatitis occurred in the first third of the simulated time, we could save time by running the 
model only 3,500 days instead of 11,000 days. However when we fix this behavior, we will 
again face a timing problem and it will become even more important if we want to follow our 
patients for an entire lifetime (for example 50-60 years or longer). The main problem is that the 
program does relatively small calculations and repeats them an enormous number of times. This 
leads to overloading of the CPU, while using very little RAM. One possible solution would be to 
rewrite portions of the code to implement parallelization. Currently we used a powerful computer 
resource, called the Gattaca cluster, to run our simulation. We were able to submit our simulation 
multiple times, where each simulation was run independently from others. Thus, we could 
submit 13 simulations and have them all finish in the time required for one simulation, which is 
about 10 hour s. In order to save computational time and allow the simulation to be more 
effective at using resources within a single computer (such as modern multi-core processors), we 
need to break the computations within a single simulation itself into individual, independent 
components. OpenMP38 or pthreads39 libraries could be used for this purpose. The basic idea is 
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to define a point where the main flow of operation could be divided into several sub operations, 
which then could be run simultaneously. After a successful completion of all sub operations the 
results from each of them are synchronized into one and then the main flow of operation 
continues. In my opinion the best choice would be to divide simulation among patients. We 
designed the model such that the whole simulation is repeated for each patient. Basically we 
looped the main core of the model for all patients and this loop is located at the very beginning 
of the program. In order to quickly parallelize this calculation, we could define 10 groups of 10 
patients each and run all groups simultaneously. This would require some changes to the loop 
itself, but not within it. An alternative solution would be to deal with the matrix that corresponds 
to the pancreas. We could separate tasks by columns or by rows. The idea remains the same, but 
it would require making many more changes within the program. 
4.3.4 Switch to deterministic model 
We built the general framework of the model such that each part of the model operates 
separately. Each step used a stochastic approach to produce some results that then were used in 
the next step as an input. This approach is good for a pilot study where one wants to test the 
general flow of the model and test whether it works in a desired sequence. In order to make this 
model more realistic so that it could be able to model causes of pancreatitis and then be used for 
more accurate predictions we would like reduce the usage of the stochastic approach to an 
acceptable degree and apply more of a deterministic approach to the model. Due to the design of 
our model we can work on every part of it individually. We can even replace some parts with 
already existing mathematical models. For example, there is an already existing mathematical 
model of the pancreatic duct cells suggested by Whitcomb and Ermentrout (2004)40 that would 
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be suitable for this purpose. The Whitcomb/Ermentrout model explains the basis of generating 
high bicarbonate concentrations in pancreatic juice. Most importantly it g ives insight into the 
workings of CFTR and some possible outcomes of CFTR mutations. We believe that with few 
adjustments we could successfully incorporate this mathematical model into our pancreatic 
model. By adopting this mathematical model we would be able to focus our efforts more on 
modeling influences of bicarbonate rich fluid on trypsinogen activation. 
It is worth mentioning that the accuracy of any mathematical model is directly dependent 
on our current understanding of the biology of the processes we try to model. I doubt that we 
fully understand the whole complexity of these processes, which means that the equations we use 
to model biological processes are not as good as we would like them to be. We still have much 
room for improvement. 
4.3.5 Include more factors 
As I mentioned before our model is considered to be a framework, each part of which needs to 
be improved. We would like to concentrate our main effort on modeling the acinar cell. 
Currently the acinar cell, in our model, is modeled using random number generator with only one 
stimulus and it only produces molecules such as trypsinogen and PSTI. I think that we need to 
add another stimulus such as food intake. Surely the amount and quality of food we eat 
influences pancreas function, but indirectly through hormones and other signals. Our model is 
not mature enough to capture these transitional signaling pathways. One way that we would like 
to improve our model is to allow it to capture all the complexity of interaction between signals 
such as acetylcholine (ACh) of vagal nerve stimulation and cholecystokinin (CCK) and secretin 
of duodenum. 
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One of the main changes we need to do in order to make the model more comparable to 
the real data is to assign more appropriate units to all substrates of the model. Currently we 
assigned number of molecules to trypsinogen, trypsin, PSTI, calcium and bicarbonate; however 
real data deal with concentrations rather than molecules. In this work we tried to model the 
pancreas in general, which is why we thought that as long we keep amount of substrates 
proportional to each other it would suffice to count number of the molecules in the model.  
However, I think that in order to make results of this model more compatible to the real data it 
would be reasonable to use concentrations of above substrates instead of number of the 
molecules whenwe further developthe model. 
In our model, inappropriate calcium levels directly influences trypsinogen activation, but 
the biological role of calcium is not limited to this one function. In intracellular environments, 
calcium plays the role of mediator for both acetylcholine and cholecystokinin signaling. It would 
be very important to us to include this function of calcium as well.  
In the current model we apply one signal for stimulation and responses from different 
acini are the same. However it might be interesting in the future to make stimulation of different 
parts of pancreas proportional to the level of stimulation. This will become important to model 
feedback regulation and hyperstimulation. 
Probably it would be a good idea to model other functions of duct cell. The duct not only 
produces fluid and reduces the calcium concentration in the lumen, but it maintains a high pH, 
which makes trypsin inactive until the pH normalizes. Currently we have variables that describe 
water and calcium, but not pH. It would be a very good improvement to the model if we could 
model influence of pH as well. 
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We need to increase the number of possible statuses of the acinus. These statusesshould 
be living or dead, with living divided into resting or secreting, and the state being either naive or 
stress-response (e.g., making PSTI).Please recall thatPSTI is the product of the SPINK1 gene 
and is normally not synthesized. They are only made by the acinar cells during a stress response. 
In order to model disease we need to include other cell types such as islet cells and 
inflammatory cells including stellate cells, macrophages and other leukocytes. 
We need to modify inflammation to be able to distinguish between acute and chronic 
inflammations. It would be very useful for modeling either acute or chronic pancreatitis. And we 
also need to modify the causes of injury. We should consider the possibility that injury can occur 
through mechanisms different than trypsinogen activation. Also, injury and inflammation is not 
the sameand loss of the acinar cell mass can occur through many pathways. 
We may need to include other environmental effects like alcohol or smoking. 
Environmental factors play a major role in clinical pancreatitis. By including them in the model 
we would have means to accurately evaluate their effects on survival function of the pancreatitis. 
Finally our model lacks the memory that passes from day to day in the simulation. 
Currently we record the total number of acini, the number of the acinar cells in each acinus and 
both local and general inflammations. However in the case of successful implementation of the 
improvements listed above we would have records of much more variables that pass from day to 
day in the simulation. We think that increased number of variables that can be followed during 
the simulation will dramatically improve chances of better understanding the pancreas and 
related risk of the pancreatitis. 
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4.4 WHAT IS THE APPLICATION? 
Based on ou r plans we will reduce randomness of the model by switching to deterministic 
modeling and include more factors like different stimuli. This will give us a good opportunity to 
provide insight into pancreatitis in terms of production and activation of trypsinogen. By altering 
different aspects of the model we will be able to mimic the effects of mutations that disrupt the 
normal work of the pancreas. Currently we divide mutations into 5 groups, those that have an 
effect on t rypsinogen production, trypsinogen activation, PSTI production, trypsin inactivation, 
and bicarbonate secretion (CFTR mutations). We treat mutations as changes in these rate 
constants, and included them to the model by simply multiplying the respective rate by a 
constant. This is a very straightforward way of adding mutational effects to the model. Once our 
model becomes mature we will be able to interpret the effects of these mutations more 
accurately, and perhaps even predict expected mutations in individuals based on t heir clinical 
course. 
The prediction of risk of developing pancreatitis due to these mutations is main goal of 
our work. In our current work, we tested the sensitivity of the model due to changes of the 
working parameters including variables that represent mutations. We continue the work on 
developing the model and we believe that this model, once fully developed, will have the power 
to make predictions of the risk of developing pancreatitis for individuals from the general 
population and for those who inherited disease-related mutations. 
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APPENDIX A: ORIGINAL CODE 
#include <string> #include <iostream> #include <fstream> #include <vector> #include <math.h> #include <time.h> #include </Developer/Headers/Matrix.h> #include </Developer/Headers/MatrixIO.h>  usingnamespacestd;  //We store all parameters in a single vector. To make things easier we gave unique names to digits from 0 to 23. //Then we use the names as indexes whenever we want to refer to the parameter vector.  //Here is interpretation of names we used. //0 Tg – Trypsinogen //1 P – PSTI //2 Ca - Calcium //3 BC - Bicarbonate //4 W – Water //5 I - Inflammation //6 D1 – Number of branches in main duct //7 D2 – Number of branches in secondary duct //8 D3 – Number of acinar cells in the acinus //9 M – Food intake, meal variable (reserved variable for future use) //10 Tg_p – Trypsinogen production //11 Tg_a – Trypsynigen activation //12 T_i – Trypsin inactivation //13 P_p – PSTI production //14 CF – CFTR mutation //15 CA - Trypsin activation in the cell (it is different from Ca, because C++ is case sensitive) //16 LA - Trypsin activation in the lumen  //17 DA - Trypsin activation in the duct //18 MR – Molecule range //19 Thr – Threshold for inflammation //20 NP – Number of patients  //21 ND – Munber of days //22 NA – Total number of acini //23 NC – Total number of acinar cells  enummol_code1 {Tg=0, P=1, Ca=2, Cl=3, W=4, I=5, D1=6, D2=7, D3=8, M=9, Tg_p=10, Tg_a=11, T_i=12, P_p=13, CF=14, CA=15, LA=16, DA=17, MR=18, Thr=19, NP=20, ND=21, NA=22, NC=23};    //This is a function that adds some random error.  //x1 - is the number we want to change. //x2 - is a range from which error is drawn. //used when TG, PSTI, Ca, and BC are assigned in the cells.  double err(double x1, double x2){  int n1, n2;  double n3;  bool b=1; 
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 while (b){   n1=rand()%101-50;   n2=rand()%101;   if (101-abs(2*n1)>n2) b=0;  }  n3=x1+x1*x2*n1/50;  return n3; }    //This function returns randomly chosen numbers from 0 to 1 with uniform distribution. The numbers are rounded to second digit  //after point. Used in functions that activate trypsinogen in cell, lumen and duct.  double perc(double x){  double n=x*(rand()%101)/100;  return n; }    //This function is used in trypsinogen activation. It makes sure that calcium has no effect //on the trypsinogen activation without inflammation.  double cum(double infl, double calcium){  if (infl==1) return1;  elsereturn infl*calcium; }    //This function creates a vector filled with numbers that correspond to molecules produced by //acinar cell. It uses two vectors that store model parameters and lumen parameters.  vector<double> stimulate_A(vector<double>& vl, vector<double>& vp){  vector<double> temp (6);  temp[Tg] = err(vp[Tg],vp[MR])*vp[Tg_p];  temp[P] = err(vp[P],vp[MR])*pow(vl[I],2)*vp[P_p];  temp[Ca] = err(1,vp[MR])*(1+(vl[I]-1)/2);  temp[Cl] = err(1,vp[MR]);  temp[W] = 1;  temp[I] = vl[I];  return temp; }    //This function activates some portion of trypsinogen in the acinar cell. Then it checks //whether existing PSTI molecules are enough to stop active trypsin from causing damage. //If existing PSTI molecules are not enough, acinar cell is destroyed.  bool check_T_cell(vector<double>& vt, vector<double>& vp){  bool b=0;  double p=perc(vp[CA]);  double temp=(vt[Tg]-vt[P])*p*cum(vt[I],vt[Ca])*vp[Tg_a]/vp[T_i];  if (temp<vp[Thr]) {vt[Tg]*=p; vt[P]*=p; b=1;}  return b; }    //the same idea, but for whole acinus  bool check_T_lumen(vector<double>& vl, vector<double>& vp){  bool b=0;  double p=perc(vp[LA]);  double temp=vl[Tg]*p*cum(vl[I],vl[Ca])*vp[Tg_a]/vp[T_i];  if (temp<=vl[P]) {vl[Tg]-=temp; vl[P]-=temp; b=1;}  return b; 
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}    //the same idea, but for whole pancreas  bool check_T_duct(vector<double>& vd, vector<double>& vp){  bool b=0;  double p=perc(vp[DA]);  double temp=vd[Tg]*p*cum(vd[I],vd[Ca])*vp[Tg_a]/(vp[T_i]*vp[W]);  if (temp<=vd[P]) {vd[Tg]-=temp; vd[P]-=temp; b=1;}  return b; }   //Once this function is called it increases inflammation to 0.5, but don't allow inflammation exceed 2 (its maximum level)  void increase_I(double& infl){  if (1<=infl and infl<=1.5) infl+=0.5;  elseif (1.5<infl and infl<=2) infl=2;  elsethrow1; }    //This function designed to reduce inflammation each time it called, but don't allow inflammation be lower than 1 (its minimum level)  void reduce_I(double& infl){  if (1<=infl and infl<1.05) infl=1;  elseif (1.05<=infl and infl<=2) infl-=0.05;  elsethrow2; }    //********************* //***    *** //*** Acinus  *** //***    *** //*********************  class A{ public:   //This function returns first or second number stored in the "status" vector.  //Because these two numbers take only 0 or 1, we can also interpreted them as Boolean.    bool get_status(int index){   bool b;   if (index==0or index==1) b=status[index];   elsethrow3;   return b;  }        //This function returns 3rd number of the "status" vector,  //that corresponds to number of active acinar cells in the acinus.    int get_cells(){returnstatus[2];}        //This function designed to reduce inflammation each time it called, but for acinus.    void reduce_acinus_I(){   if (1<=lum[I] andlum[I]<1.05) lum[I]=1;   elseif (1.05<=lum[I] andlum[I]<=2) lum[I]-=0.05;   elsethrow4; 
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 }       //This function generates acinus or simply fills up both vectors of class A (acinus).  void gen_acinus(vector<double>& vp){   status.push_back(1);  //Means that acinus is working   status.push_back(0);  //Means that acinus was never destroyed   status.push_back(vp[D3]); //Number of active cells in the acinus      //Fills first four numbers of vector, that correspont Tg, P, Ca, Cl respectively.   for(int i=0; i<4; i++) lum.push_back(0);   lum.push_back(1);   //water   lum.push_back(vp[I]);  //inflammation that takes value from general inflammation.  }        //The same as previous function, but this time second number of vector "status"   //takes value of 1, meaning that this particular acinus was destroyed once.   void regen_acinus(vector<double>& vp){   status.clear();   status.push_back(1);   status.push_back(1);   status.push_back(vp[D3]);      lum.clear();   for(int i=0; i<4; i++) {lum.push_back(0);}   lum.push_back(1);   lum.push_back(vp[I]);  }        //Main function of class A (acinus)  bool stimulate_acinus(vector<double>& vp){    bool li=0;  //Indicator whether damage happened in the lumen    vector<double> vtemp; //A vector to store temporary numbers   int dead=0;  //Number of dead acing cells         //This loop designed to call function that stimulate acinar cell the same   //times as number of active acinar cells in the acinus. It also checks    //whether something happened in the acinar cell itself.   for (int i=0; i<status[2]; i++){    vtemp = stimulate_A(lum, vp);    if (check_T_cell(vtemp, vp))     for (int i=0; i<4; i++)      lum[i]+=vtemp[i];    else dead++;    vtemp.clear();   }      //Increases inflammation if any acinar cell died   if (dead>0) increase_I(lum[I]);    //There are two conditions when acinus supposed to be destroyed:   //when all acinar cells in the acinus die or activated trypsin exceeds existing PSTI.   //In other cases acinus continues to work, but number of active acinar cells is reduced    //to number of acinar cells that died during simulation.      if (dead<status[2]){    status[2]-=dead;        for (int i=0; i<4; i++) lum[i]/=status[2]; //average molecules in the pancreatic juice        //This step was taken to show that Ca level in the lumen are     //increased compared to level inside acinar cell. 
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   lum[Ca]*=vp[Ca];     //Checks whether existing PSTI molecules enough to stop activation    //of trypsinogen in the lumen.    if (check_T_lumen(lum, vp)){     lum[W]=vp[W]*lum[Cl]*vp[CF];   //Increase level of water     li=1;    }    elsestatus[0]=0;   }   elsestatus[0]=0;      //If nothing happens with acinus or with any of it's acing cells,   //the inflammation is reduced.   if (status[0] and dead==0) reduce_acinus_I();    dead=0;   return li;  }        //This function helps to collect all molecules from lumen to duct.  //Or simply add corresponding numbers to a vector that represents duct.  void collect(vector<double>& vd){   for (int i=0; i<5; i++) {vd[i]+=lum[i];}   //Reset vector, so we can use it again for next acinus.   lum[Tg]=lum[P]=lum[Ca]=lum[Cl]=0; lum[W]=1;  }        //Synchronize inflammation from entire pancreas to particular acinus.  //Makes sure that local inflammation not less than general inflammation.  void sync_acinus(vector<double>& vp){   if (vp[I]>lum[I]) lum[I]=vp[I];  }        //Recover number of acinar cells if it dramatically drops down.  void regen_cells(vector<double>& vp){   if (status[2]<=vp[D3]/2){    status[2]=vp[D3];    lum[I]=vp[I];   }  }  private:  //This vector stores three numbers: 1st two numbers correspond to status of acinus itself  //and indicator of whether acinus was destroyed or not respectively. These two numbers   //takes only two values (0 and 1) and can be interpreted as Boolean. 3rd number corresponds  //to number of active acinar cells in the acinus.    vector<int>status;    //This vector contains six numbers. Their position as following: trypsinogen, PSTI,   //calcium, chloride, water, and inflammation of the acinus.   vector<double>lum; };    //********************* //***    *** //*** Matrix  *** //***    *** //********************* 
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 typedef Numeric_lib::Matrix<A,2> Matrix;   //This function creates a matrix with defined numbers of rows and columns. //It also fills each cell of the matrix with empty acinus.  void gen_matrix(Matrix& f, vector<double>& vp){  for(int i=0; i<f.dim1(); i++)    for(int j=0; j<f.dim2(); j++)    f(i,j).gen_acinus(vp); }   //When called this function finds acini and renew them. void regen_matrix(Matrix& f, vector<double>& vp){  for(int i=0; i<f.dim1(); i++)    for(int j=0; j<f.dim2(); j++)    if (!f(i,j).get_status(0) and !f(i,j).get_status(1)) f(i,j).regen_acinus(vp); }    //This function starts whole simulation of the matrix (pancreas). vector<double> stimulate_matrix(Matrix& f, vector<double>& vp, bool& di){   //This vector is for temporary use.  //It has 5 empty numbers plus 6th one, equal to general inflammation.  vector<double> vtemp (5);  vtemp.push_back(vp[I]);  int count=0;   //Counts how many acini worked in one simulation  for(int i=0; i<f.dim1(); i++)   for(int j=0; j<f.dim2(); j++)    if (f(i,j).get_status(0)){ //Check whether acini is ready to work     f(i,j).regen_cells(vp);//Fills up acinus with acinar cells if needed     f(i,j).sync_acinus(vp);//Synchronize inflammation along whole pancreas         //Stimulate acinus and then collect produced molecules (juice) to main duct     if (f(i,j).stimulate_acinus(vp)) {f(i,j).collect(vtemp); count++;}     else {di=1;} //Indicates whether something went wrong.    }  //average each type of collected molecules in the main duct  //then further increase Ca level  for(int i=0; i<5; i++) vtemp[i]/=count;  vtemp[Ca]*=vp[Ca];  return vtemp; }    //Report total number of active acini and acinar cells it returns FALSE when everything is OK //and TRUE when number of acini is too small. In other words this function indicates whether // recoveryof panaceas is required bool report(Matrix& f, vector<double>& vp){  bool r=0;  vp[NA]=vp[NC]=0;  for(int i=0; i<f.dim1(); i++)   for(int j=0; j<f.dim2(); j++)    if (f(i,j).get_status(0)){     vp[NA]++;     vp[NC]+=f(i,j).get_cells();    }  if (vp[NA]<(vp[D1]*vp[D2]/10)) r=1;  return r; }    //***************************** 
  54 
//***     *** //*** Main Function  *** //***     *** //*****************************  int main (){ try{  srand(time(NULL));  //Turn on random number generator  vector<double> param, param2; //Used to store parameters from external file  vector<int> days;  //Used to catch days when pancreatitis attacks occurred  doublevalue;   //Temporary number     while (!(cin>>ws).eof()){   cin>>value;   param.push_back(value);  }    //The vector that store parameters is constantly modified during the simulation  //to keep initial set of parameters intact we copy it to second vector.   param2=param;      cout<<"ID\tTime\tStatus\tGroup\n";  for(int n=1; n<=param[NP]; n++){ //Loop whole simulation for number of patients   bool AP=0, Di=0;   //Indicators of pancreatitis and duct inflammation   days.clear();      Matrix frame (param[D1], param[D2]);  //Create matrix   gen_matrix(frame, param);   //Fill matrix   vector<double> juice;    //Temporary vector      for (int i=0; i<param[ND]; i++){  //Loop simulation for number of days    if (report(frame, param))regen_matrix(frame, param); //Regenerate acini if needed    juice=stimulate_matrix(frame, param, Di); //Collect juice (produced molecules from all acini)      if (Di) increase_I(param[I]);   //Increase general inflammation in response to acinus death    if (check_T_duct(juice, param)) {  //This part activates some trypsinogen and checks if PSTI is enough to avoid dammage     if (!Di)       reduce_I(param[I]);  //This part is a little tricky due to complexity of conditions whether general inflammation is needed to be reduced or increased      reduce_I(param[I]);         }    elseif (!Di) increase_I(param[I]);     Di=0;      //Reset Di     //These set of conditions are designed to catch time when pancreatitis    //attacks were occurred and stop simulation after 3rd attack or total    //number of acinar cells is too small (the last condition was never true)    if (param[I]>1.5and !AP) {days.push_back(i/30); AP=1;}    if (param[I]==1) AP=0;    if ((param[NC]<100) || (days.size()==3)) {     days.push_back(0);     i=param[ND];    }   }          //These set of conditions help to make output looks nice   if (days.size()>0) {cout<<n <<"\t"<<days[0] <<"\t1\t1\n";}   else {cout<<n <<"\t"<<ceil(param[ND]/7) <<"\t0\t1\n";}      if (days.size()>1) {cout<<n <<"\t"<<days[1] <<"\t1\t2\n";}   else {cout<<n <<"\t"<<ceil(param[ND]/7) <<"\t0\t2\n";}    if (days.size()>2) {cout<<n <<"\t"<<days[2] <<"\t1\t3\n";}   else {cout<<n <<"\t"<<ceil(param[ND]/7) <<"\t0\t3\n";} 
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     param=param2;  //reset parameters and use them again for next patient  }  return0; } catch (int e) {   cerr<<"\nError in "<<e <<endl; } } 
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APPENDIX B: REVISED CODE 
#include <string> #include <iostream> #include <fstream> #include <vector> #include <math.h> #include <time.h> #include </Developer/Headers/Matrix.h> #include </Developer/Headers/MatrixIO.h>  usingnamespacestd;  //We store all parameters in a single vector. To make things easier we gave unique names to digits from 0 to 23. //Then we use the names as indexes whenever we want to refer to the parameter vector.  //Here is interpretation of names we used. //0 Tg – Trypsinogen //1 P – PSTI //2 Ca - Calcium //3 BC - Bicarbonate //4 W – Water //5 I - Inflammation //6 D1 – Number of branches in main duct //7 D2 – Number of branches in secondary duct //8 D3 – Number of acinar cells in the acinus //9 M – Food intake, meal variable (reserved variable for future use) //10 Tg_p – Trypsinogen production //11 Tg_a – Trypsynigen activation //12 T_i – Trypsin inactivation //13 P_p – PSTI production //14 CF – CFTR mutation //15 CA - Trypsin activation in the cell (it is different from Ca, because C++ is case sensitive) //16 LA - Trypsin activation in the lumen  //17 DA - Trypsin activation in the duct //18 MR – Molecule range //19 Thr – Threshold for inflammation //20 NP – Number of patients  //21 ND – Munber of days //22 NA – Total number of acini //23 NC – Total number of acinar cells  enummol_code1 {Tg=0, P=1, Ca=2, BC=3, W=4, I=5, D1=6, D2=7, D3=8, M=9, Tg_p=10, Tg_a=11, T_i=12, P_p=13, CF=14, CA=15, LA=16, DA=17, MR=18, Thr=19, NP=20, ND=21, NA=22, NC=23};    //This is a function that adds some random error.  //x1 - is the number we want to change. //x2 - is a range from which error is drawn. //used when TG, PSTI, Ca, and BC are assigned in the cells.  double err(double x1, double x2){  int n1, n2;  double n3;  bool b=1; 
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 while (b){   n1=rand()%101-50;   n2=rand()%101;   if (101-abs(2*n1)>n2) b=0;  }  n3=x1+x1*x2*n1/50;  return n3; }    //This function returns randomly chosen numbers from 0 to 1 with uniform distribution. The numbers are rounded to second digit  //after point. Used in functions that activate trypsinogen in cell, lumen and duct.  double perc(double x){  double n=x*(rand()%101)/100;  return n; }    //This function is used in trypsinogen activation. It makes sure that calcium has no effect //on the trypsinogen activation without inflammation.  double cum(double infl, double calcium){  if (infl==1) return1;  elsereturn infl*calcium; }    //This function creates a vector filled with numbers that correspond to molecules produced by //acinar cell. It uses two vectors that store model parameters and lumen parameters.  vector<double> stimulate_A(vector<double>& vl, vector<double>& vp){  vector<double> temp (6);  temp[Tg] = err(vp[Tg],vp[MR])*vp[Tg_p];  temp[P] = err(vp[P],vp[MR])*pow(vl[I],2)*vp[P_p];  temp[Ca] = err(1,vp[MR])*(1+(vl[I]-1)/2);  temp[BC] =0;  temp[W] = 0;  temp[I] = vl[I];  return temp; }    //This function activates some portion of trypsinogen in the acinar cell. Then it checks //whether existing PSTI molecules are enough to stop active trypsin from causing damage. //If existing PSTI molecules are not enough, acinar cell is destroyed.  bool check_T_cell(vector<double>& vt, vector<double>& vp){  bool b=0;  double p=perc(vp[CA]);  double temp=(vt[Tg]-vt[P])*p*cum(vt[I],vt[Ca])*vp[Tg_a]/vp[T_i];  if (temp<vp[Thr]) {vt[Tg]*=p; vt[P]*=p; b=1;}  return b; }    //the same idea, but for whole acinus  bool check_T_lumen(vector<double>& vl, vector<double>& vp){  bool b=0;  double p=perc(vp[LA]);  double temp=vl[Tg]*p*cum(vl[I],vl[Ca])*vp[Tg_a]/vp[T_i];  if (temp<=vl[P]) {vl[Tg]-=temp; vl[P]-=temp; b=1;}  return b; 
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}    //the same idea, but for whole pancreas  bool check_T_duct(vector<double>& vd, vector<double>& vp){  bool b=0;  double p=perc(vp[DA]);  double temp=vd[Tg]*p*cum(vd[I],vd[Ca])*vp[Tg_a]/vp[T_i];  if (temp<=vd[P]) {vd[Tg]-=temp; vd[P]-=temp; b=1;}  return b; }   //Once this function is called it increases inflammation to 0.5, but don't allow inflammation exceed 2 (its maximum level)  void increase_I(double& infl){  if (1<=infl and infl<=1.5) infl+=0.5;  elseif (1.5<infl and infl<=2) infl=2;  elsethrow1; }    //This function designed to reduce inflammation each time it called, but don't allow inflammation be lower than 1 (its minimum level)  void reduce_I(double& infl){  if (1<=infl and infl<1.05) infl=1;  elseif (1.05<=infl and infl<=2) infl-=0.05;  elsethrow2; }    //********************* //***    *** //*** Acinus  *** //***    *** //*********************  class A{ public:   //This function returns first or second number stored in the "status" vector.  //Because these two numbers take only 0 or 1, we can also interpreted them as Boolean.    bool get_status(int index){   bool b;   if (index==0or index==1) b=status[index];   elsethrow3;   return b;  }        //This function returns 3rd number of the "status" vector,  //that corresponds to number of active acinar cells in the acinus.    int get_cells(){returnstatus[2];}        //This function designed to reduce inflammation each time it called, but for acinus.    void reduce_acinus_I(){   if (1<=lum[I] andlum[I]<1.05) lum[I]=1;   elseif (1.05<=lum[I] andlum[I]<=2) lum[I]-=0.05;   elsethrow4; 
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 }       //This function generates acinus or simply fills up both vectors of class A (acinus).  void gen_acinus(vector<double>& vp){   status.push_back(1);  //Means that acinus is working   status.push_back(0);  //Means that acinus was never destroyed   status.push_back(vp[D3]); //Number of active cells in the acinus      //Fills first four numbers of vector, that correspont Tg, P, Ca, Cl respectively.   for(int i=0; i<4; i++) lum.push_back(0);   lum.push_back(1);  //water   lum.push_back(vp[I]);  //inflammation that takes value from general inflammation.  }        //The same as previous function, but this time second number of vector "status"   //takes value of 1, meaning that this particular acinus was destroyed once.   void regen_acinus(vector<double>& vp){   status.clear();   status.push_back(1);   status.push_back(1);   status.push_back(vp[D3]);      lum.clear();   for(int i=0; i<4; i++) {lum.push_back(0);}   lum.push_back(1);   lum.push_back(vp[I]);  }        //Main function of class A (acinus)  bool stimulate_acinus(vector<double>& vp){    bool li=0;  //Indicator whether damage happened in the lumen    vector<double> vtemp; //A vector to store temporary numbers   int dead=0;  //Number of dead acing cells         //This loop designed to call function that stimulate acinar cell the same   //times as number of active acinar cells in the acinus. It also checks    //whether something happened in the acinar cell itself.   for (int i=0; i<status[2]; i++){    vtemp = stimulate_A(lum, vp);    if (check_T_cell(vtemp, vp))     for (int i=0; i<4; i++)      lum[i]+=vtemp[i];    else dead++;    vtemp.clear();   }      //Increases inflammation if any acinar cell died   if (dead>0) increase_I(lum[I]);    //There are two conditions when acinus supposed to be destroyed:   //when all acinar cells in the acinus die or activated trypsin exceeds existing PSTI.   //In other cases acinus continues to work, but number of active acinar cells is reduced    //to number of acinar cells that died during simulation.      if (dead<status[2]){    status[2]-=dead;        for (int i=0; i<4; i++) lum[i]/=lum[W]; //dilute molecules in the main duct        //This step was taken to show that Ca level in the lumen are     //increased compared to level inside acinar cell. 
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   lum[Ca]*=vp[Ca];     //Checks whether existing PSTI molecules enough to stop activation    //of trypsinogen in the lumen.    if (check_T_lumen(lum, vp)){     lum[BC]=err(1,vp[MR]); //Assign bicarbonate     lum[W]=vp[W]*lum[BC]*vp[CF];   //Increase level of water     li=1;    }    elsestatus[0]=0;   }   elsestatus[0]=0;      //If nothing happens with acinus or with any of it's acing cells,   //the inflammation is reduced.   if (status[0] and dead==0) reduce_acinus_I();    dead=0;   return li;  }        //This function helps to collect all molecules from lumen to duct.  //Or simply add corresponding numbers to a vector that represents duct.  void collect(vector<double>& vd){   for (int i=0; i<5; i++) {vd[i]+=lum[i];}   //Reset vector, so we can use it again for next acinus.   lum[Tg]=lum[P]=lum[Ca]=lum[BC]=0; lum[W]=1;  }        //Synchronize inflammation from entire pancreas to particular acinus.  //Makes sure that local inflammation not less than general inflammation.  void sync_acinus(vector<double>& vp){   if (vp[I]>lum[I]) lum[I]=vp[I];  }        //Recover number of acinar cells if it dramatically drops down.  void regen_cells(vector<double>& vp){   if (status[2]<=vp[D3]/2){    status[2]=vp[D3];    lum[I]=vp[I];   }  }  private:  //This vector stores three numbers: 1st two numbers correspond to status of acinus itself  //and indicator of whether acinus was destroyed or not respectively. These two numbers   //takes only two values (0 and 1) and can be interpreted as Boolean. 3rd number corresponds  //to number of active acinar cells in the acinus.    vector<int>status;    //This vector contains six numbers. Their position as following: trypsinogen, PSTI,   //calcium, chloride, water, and inflammation of the acinus.   vector<double>lum; };    //********************* //***    *** //*** Matrix  *** //***    *** 
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//*********************  typedef Numeric_lib::Matrix<A,2> Matrix;   //This function creates a matrix with defined numbers of rows and columns. //It also fills each cell of the matrix with empty acinus.  void gen_matrix(Matrix& f, vector<double>& vp){  for(int i=0; i<f.dim1(); i++)    for(int j=0; j<f.dim2(); j++)    f(i,j).gen_acinus(vp); }   //When called this function finds acini and renew them. void regen_matrix(Matrix& f, vector<double>& vp){  for(int i=0; i<f.dim1(); i++)    for(int j=0; j<f.dim2(); j++)    if (!f(i,j).get_status(0) and !f(i,j).get_status(1)) f(i,j).regen_acinus(vp); }    //This function starts whole simulation of the matrix (pancreas). vector<double> stimulate_matrix(Matrix& f, vector<double>& vp, bool& di){   //This vector is for temporary use.  //It has 5 empty numbers plus 6th one, equal to general inflammation.  vector<double> vtemp (5);  vtemp.push_back(vp[I]);  int count=0;   //Counts how many acini worked in one simulation  for(int i=0; i<f.dim1(); i++)   for(int j=0; j<f.dim2(); j++)    if (f(i,j).get_status(0)){ //Check whether acini is ready to work     f(i,j).regen_cells(vp);//Fills up acinus with acinar cells if needed     f(i,j).sync_acinus(vp);//Synchronize inflammation along whole pancreas         //Stimulate acinus and then collect produced molecules (juice) to main duct     if (f(i,j).stimulate_acinus(vp)) {f(i,j).collect(vtemp); count++;}     else {di=1;} //Indicates whether something went wrong.    }  vtemp[Ca]*=vp[Ca];  //Increase calcium level  return vtemp; }    //Report total number of active acini and acinar cells it returns FALSE when everything is OK //and TRUE when number of acini is too small. In other words this function indicates whether //recovery of panaceas is required bool report(Matrix& f, vector<double>& vp){  bool r=0;  vp[NA]=vp[NC]=0;  for(int i=0; i<f.dim1(); i++)   for(int j=0; j<f.dim2(); j++)    if (f(i,j).get_status(0)){     vp[NA]++;     vp[NC]+=f(i,j).get_cells();    }  if (vp[NA]<(vp[D1]*vp[D2]/10)) r=1;  return r; }    //***************************** //***     *** //*** Main Function  *** 
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//***     *** //*****************************  int main (){ try{  srand(time(NULL));  //Turn on random number generator  vector<double> param, param2; //Used to store parameters from external file  vector<int> days;  //Used to catch days when pancreatitis attacks occurred  doublevalue;   //Temporary number     while (!(cin>>ws).eof()){   cin>>value;   param.push_back(value);  }    //The vector that store parameters is constantly modified during the simulation  //to keep initial set of parameters intact we copy it to second vector.   param2=param;      cout<<"ID\tTime\tStatus\tGroup\n";  for(int n=1; n<=param[NP]; n++){ //Loop whole simulation for number of patients   bool AP=0, Di=0;   //Indicators of pancreatitis and duct inflammation   days.clear();      Matrix frame (param[D1], param[D2]); //Create matrix   gen_matrix(frame, param);  //Fill matrix   vector<double> juice;   //Temporary vector      for (int i=0; i<param[ND]; i++){  //Loop simulation for number of days    if (report(frame, param))regen_matrix(frame, param); //Regenerate acini if needed    juice=stimulate_matrix(frame, param, Di); //Collect juice (produced molecules from all acini)      if (Di) increase_I(param[I]);   //Increase general inflammation in response to acinus death    if (check_T_duct(juice, param)) {  //This part activates some trypsinogen and checks if PSTI is enough to avoid dammage     if (!Di)       reduce_I(param[I]); //This part is a little tricky due to complexity of conditions whether general inflammation is needed to be reduced or increased      reduce_I(param[I]);         }    elseif (!Di) increase_I(param[I]);     Di=0;     //Reset Di     //These set of conditions are designed to catch time when pancreatitis    //attacks were occurred and stop simulation after 3rd attack or total    //number of acinar cells is too small (the last condition was never true)    if (param[I]>1.5and !AP) {days.push_back(i/30); AP=1;}    if (param[I]==1) AP=0;    if ((param[NC]<100) || (days.size()==3)) {     days.push_back(0);     i=param[ND];    }   }          //These set of conditions help to make output looks nice   if (days.size()>0) {cout<<n <<"\t"<<days[0] <<"\t1\t1\n";}   else {cout<<n <<"\t"<<ceil(param[ND]/7) <<"\t0\t1\n";}      if (days.size()>1) {cout<<n <<"\t"<<days[1] <<"\t1\t2\n";}   else {cout<<n <<"\t"<<ceil(param[ND]/7) <<"\t0\t2\n";}    if (days.size()>2) {cout<<n <<"\t"<<days[2] <<"\t1\t3\n";}   else {cout<<n <<"\t"<<ceil(param[ND]/7) <<"\t0\t3\n";}      param=param2;  //reset parameters and use them again for next patient 
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 }  return0; } catch (int e) {   cerr<<"\nError in "<<e <<endl; } } 
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